Beta-adrenergic blockade following thrombolytic therapy: Is it helpful or harmful?
Publication
, Journal Article
Becker, RC
Published in: Clinical Cardiology
1994
Beta-adrenergic blockade has been a mainstay in the treatment of patients with acute myocardial infarction for nearly two decades. Clearly, it has withstood the test of time. The emergence of thrombolytic therapy, however, has shifted the medical community's focus, raising questions as to the benefit of beta-adrenergic blockade. Although further investigation is warranted, the available evidence suggests that beta blockers can be given safely to selected patients following coronary thrombolysis, particularly in the absence of moderate to severe left ventricular dysfunction.
Duke Scholars
Published In
Clinical Cardiology
Publication Date
1994
Volume
17
Issue
4
Start / End Page
171 / 174
Related Subject Headings
- Cardiovascular System & Hematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (1994). Beta-adrenergic blockade following thrombolytic therapy: Is it helpful or harmful? Clinical Cardiology, 17(4), 171–174.
Becker, R. C. “Beta-adrenergic blockade following thrombolytic therapy: Is it helpful or harmful?” Clinical Cardiology 17, no. 4 (1994): 171–74.
Becker RC. Beta-adrenergic blockade following thrombolytic therapy: Is it helpful or harmful? Clinical Cardiology. 1994;17(4):171–4.
Becker, R. C. “Beta-adrenergic blockade following thrombolytic therapy: Is it helpful or harmful?” Clinical Cardiology, vol. 17, no. 4, 1994, pp. 171–74.
Becker RC. Beta-adrenergic blockade following thrombolytic therapy: Is it helpful or harmful? Clinical Cardiology. 1994;17(4):171–174.
Published In
Clinical Cardiology
Publication Date
1994
Volume
17
Issue
4
Start / End Page
171 / 174
Related Subject Headings
- Cardiovascular System & Hematology
- 1102 Cardiorespiratory Medicine and Haematology